These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 25588379)

  • 41. An integrated network-based mechanistic model for tumor growth dynamics under drug administration.
    Ribeiro D; Pinto JM
    Comput Biol Med; 2009 Apr; 39(4):368-84. PubMed ID: 19285661
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimizing drug regimens in cancer chemotherapy: a simulation study using a PK-PD model.
    Barbolosi D; Iliadis A
    Comput Biol Med; 2001 May; 31(3):157-72. PubMed ID: 11173054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation of pharmacokinetic/pharmacodynamic-derived predictions of antibiotic efficacy with clinical outcomes in severely ill patients with Pseudomonas aeruginosa pneumonia.
    Fish DN; Kiser TH
    Pharmacotherapy; 2013 Oct; 33(10):1022-34. PubMed ID: 23744833
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pharmacology of anticancer drugs in the elderly: tools for dose-adjustment].
    Tranchand B; Falandry C; You B; Girard P; Ribba B; Tod M; Freyer G
    Bull Cancer; 2008 May; 95 FMC Onco():F21-7. PubMed ID: 18511363
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antitumor activity of targeted and cytotoxic agents in murine subcutaneous tumor models correlates with clinical response.
    Wong H; Choo EF; Alicke B; Ding X; La H; McNamara E; Theil FP; Tibbitts J; Friedman LS; Hop CE; Gould SE
    Clin Cancer Res; 2012 Jul; 18(14):3846-55. PubMed ID: 22648270
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microdialysis: an in vivo approach for measuring drug delivery in oncology.
    Brunner M; Müller M
    Eur J Clin Pharmacol; 2002 Jul; 58(4):227-34. PubMed ID: 12136367
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mathematical modeling of efficacy and safety for anticancer drugs clinical development.
    Lavezzi SM; Borella E; Carrara L; De Nicolao G; Magni P; Poggesi I
    Expert Opin Drug Discov; 2018 Jan; 13(1):5-21. PubMed ID: 28972401
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Integration of pharmacokinetic/pharmacodynamic modeling and simulation in the development of new anti-infective agents - minimum inhibitory concentration versus time-kill curves.
    Schmidt S; Schuck E; Kumar V; Burkhardt O; Derendorf H
    Expert Opin Drug Discov; 2007 Jun; 2(6):849-60. PubMed ID: 23489002
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nociceptive stimulus modality-related difference in pharmacokinetic-pharmacodynamic modeling of morphine in the rat.
    Shang GW; Liu DN; Yan LH; Cui XY; Zhang KP; Qi C; Chen J
    Pharmacol Biochem Behav; 2006 Oct; 85(2):464-73. PubMed ID: 17126387
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacodynamic biomarkers for molecular cancer therapeutics.
    Sarker D; Workman P
    Adv Cancer Res; 2007; 96():213-68. PubMed ID: 17161682
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New concept and a theoretical consideration of the mechanism-based pharmacokinetics/ pharmacodynamics (PK/PD) modeling for antimicrobial agents.
    Sato N; Suzuki H; Hayashi H; Shibasaki S; Sugano T; Maebashi K; Kurosawa T; Shiomi M; Ogata H
    Jpn J Antibiot; 2008 Oct; 61(5):314-38. PubMed ID: 19260351
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth after administration of an anti-angiogenic agent, bevacizumab, as single-agent and combination therapy in tumor xenografts.
    Rocchetti M; Germani M; Del Bene F; Poggesi I; Magni P; Pesenti E; De Nicolao G
    Cancer Chemother Pharmacol; 2013 May; 71(5):1147-57. PubMed ID: 23430120
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improving Cancer Treatment via Mathematical Modeling: Surmounting the Challenges Is Worth the Effort.
    Michor F; Beal K
    Cell; 2015 Nov; 163(5):1059-1063. PubMed ID: 26590416
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxics.
    Paci A; Veal G; Bardin C; Levêque D; Widmer N; Beijnen J; Astier A; Chatelut E
    Eur J Cancer; 2014 Aug; 50(12):2010-9. PubMed ID: 24889915
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identifying optimal biologic doses of everolimus (RAD001) in patients with cancer based on the modeling of preclinical and clinical pharmacokinetic and pharmacodynamic data.
    Tanaka C; O'Reilly T; Kovarik JM; Shand N; Hazell K; Judson I; Raymond E; Zumstein-Mecker S; Stephan C; Boulay A; Hattenberger M; Thomas G; Lane HA
    J Clin Oncol; 2008 Apr; 26(10):1596-602. PubMed ID: 18332467
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mass Spectrometry Imaging in Oncology Drug Discovery.
    Goodwin RJ; Bunch J; McGinnity DF
    Adv Cancer Res; 2017; 134():133-171. PubMed ID: 28110649
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Population pharmacokinetic/pharmacodynamic modeling for the time course of tumor shrinkage by motesanib in thyroid cancer patients.
    Lu JF; Claret L; Sutjandra L; Kuchimanchi M; Melara R; Bruno R; Sun YN
    Cancer Chemother Pharmacol; 2010 Nov; 66(6):1151-8. PubMed ID: 20872145
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modeling oxaliplatin drug delivery to circadian rhythms in drug metabolism and host tolerance.
    Clairambault J
    Adv Drug Deliv Rev; 2007 Aug; 59(9-10):1054-68. PubMed ID: 17707544
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modeling and optimization of combined cytostatic and cytotoxic cancer chemotherapy.
    Villasana M; Ochoa G; Aguilar S
    Artif Intell Med; 2010 Nov; 50(3):163-73. PubMed ID: 20620035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.